2006
DOI: 10.1016/j.jconrel.2005.10.022
|View full text |Cite
|
Sign up to set email alerts
|

Lecithinized superoxide dismutase (PC-SOD) improved spinal cord injury-induced motor dysfunction through suppression of oxidative stress and enhancement of neurotrophic factor production

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

0
22
0

Year Published

2007
2007
2023
2023

Publication Types

Select...
7
2

Relationship

1
8

Authors

Journals

citations
Cited by 40 publications
(22 citation statements)
references
References 24 publications
0
22
0
Order By: Relevance
“…However, the low stability of Cu/Zn-SOD in plasma and its low affinity for cells form an obstacle for its clinical development. PC-SOD, a derivative of SOD with higher stability in plasma and higher affinity for tissue, thus offers an attractive alternative to Cu/Zn-SOD, and its heightened therapeutic actions were demonstrated in animal models of various inflammatory diseases such as idiopathic pulmonary fibrosis (IPF), colitis, focal cerebral ischemic injury, and spinal cord injury-induced motor dysfunction (20,37,38,40). In a phase I clinical study, intravenously administered PC-SOD (40 -160 mg) had a terminal half-life of more than 24 h, with good safety and tolerability (7,35).…”
Section: Discussionmentioning
confidence: 99%
“…However, the low stability of Cu/Zn-SOD in plasma and its low affinity for cells form an obstacle for its clinical development. PC-SOD, a derivative of SOD with higher stability in plasma and higher affinity for tissue, thus offers an attractive alternative to Cu/Zn-SOD, and its heightened therapeutic actions were demonstrated in animal models of various inflammatory diseases such as idiopathic pulmonary fibrosis (IPF), colitis, focal cerebral ischemic injury, and spinal cord injury-induced motor dysfunction (20,37,38,40). In a phase I clinical study, intravenously administered PC-SOD (40 -160 mg) had a terminal half-life of more than 24 h, with good safety and tolerability (7,35).…”
Section: Discussionmentioning
confidence: 99%
“…It would be interesting to study whether PC-SOD affects upstream cell-survival targets, such as PI3K/AKT and HIF-1. 2,7,23 Recently, lecithinized SOD has also been used in human subjects for corneal ulcers. 24 PC-SOD is a promising therapeutic option against cerebral stroke, as it may simultaneously modulate molecular targets activated in ischemia, oxidative stress, and apoptosis.…”
Section: Discussionmentioning
confidence: 99%
“…2,3 Protective effects of PC-SOD have been reported in spinal cord and traumatic brain injuries. [7][8][9] However, a potential protective role for PC-SOD in cerebral ischemic injuries has not been addressed before. Therefore, the present study was designed to study whether PC-SOD protects against neuronal apoptotic cell death in a rat model of transient focal ischemia.…”
mentioning
confidence: 99%
“…The room had a 12 h light/dark cycle. The study protocol was approved by the An- Spinal Cord Injury and Drug Treatment Impact injury of the spinal cord was induced by using the weight-drop device developed at New York University (NYU impact model), according to the method described by Takenaga et al 26,27) and Kitagawa et al 28) Adult female SD rats weighing 210-230 g were anesthetized and dorsal laminectomy was performed at the T 10 level, after which a 10 g weight was dropped onto the spinal cord from a height of 25 mm.…”
Section: Methodsmentioning
confidence: 99%